SCHEMBL29335242

SCHEMBL29335242

COc1ccc(S(=O)(=O)Nc2ccc(F)c(N)c2F)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.50
▸ MAPT P10636 2/20 0.50
▸ ACLY P53396 1/20 0.47
▸ GAA P10253 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ SLC40A1 Q9NP59 3/20 0.46
▸ CCR2 P41597 4/20 0.45
▸ AXL P30530 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ FABP4 P15090 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29335243 0.90 ALDH1A1 (0.48) ALDH1A1MAPTACLYGAAKMT2A
SCHEMBL29335260 0.89 ALDH1A1 (0.47) ALDH1A1MAPTACLYGAAKMT2A
SCHEMBL3019464 0.83 CCR2 (0.59) ACLYCCR2KCNH2POLBHSD17B10
SCHEMBL29335266 0.78 FABP4 (0.50) ALDH1A1MAPTACLYGAAKMT2A
SCHEMBL3022491 0.77 PTGES2 (0.52) ALDH1A1ACLYCCR2FABP4KDM4E
SCHEMBL22492257 0.77 SMN1; SMN2 (0.48) ALDH1A1MAPTACLYGAAKMT2A
SCHEMBL29335302 0.76 PTGES2 (0.41) ALDH1A1ACLYKMT2ASLC40A1CCR2
SCHEMBL3020003 0.76 PTGES2 (0.53) ACLYCCR2AXLHSD17B10
SCHEMBL29335270 0.76 ALDH1A1 (0.50) ALDH1A1MAPTACLYGAAKMT2A
SCHEMBL29335303 0.74 ACLY (0.39) ALDH1A1ACLYGAASMN1; SMN2SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS ALDH1A1 1786/4885MAPT 3495/4885ACLY 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback